BORTLIEVA (BORTEZOMIB INJECTION IP 2 MG /VIAL -

USD
- INR
- EUR
- - Buyer
    
    Register as a Foriegn Buyer
  - Seller
    
    Log In Register as a Seller

Get Quotations List Products

BORTLIEVA (BORTEZOMIB INJECTION IP 2 MG /VIAL

ITC-HSN: 30049095

Price on Request

Min Order Qty 1 Piece

Product not available

Bortezomib Injection IP 2mg

Brand Name BORTELIEVA 2MG

Composition Bortezomib Injection IP 2mg

Manufacture By Allieva Pharma Private Limited

Form Injection

Packing Vial

Country Of Origin India SCHEDULED DRUG USED IN ONCOLOGY PRESCRIBED BY PHYSICIANS ONLY

Prescription Required

RADHAKRUSHNA MEDICALS

Yavatmal, India

Business Operations: Merchant

Contact Seller

Share on:

Agency Request
Distributorship Request
Contract Manufacturing
Joint Venture
Buying Agents
Importers
Business Development Agencies

By clicking on ‘Send Trade Enquiry’, you agree to our terms & condition and user policies

Description
Business Information

Description

BORTLIEVA 2 mg contains Bortezomib, a reversible proteasome inhibitor that inhibits the 26S proteasome. This leads to accumulation of misfolded proteins, disruption of cellular homeostasis, and apoptosis of malignant plasma cells. It is a key drug in multiple myeloma therapy.

Uses

Bortezomib is indicated for:

1. Multiple Myeloma

– Newly diagnosed and relapsed/refractory

2. Mantle Cell Lymphoma (MCL)

– Relapsed or refractory disease

Side Effects

Common side effects:

• Peripheral neuropathy (dose-limiting)

• Thrombocytopenia, anemia

• Nausea, diarrhea, constipation

• Fatigue

Other side effects:

• Herpes zoster reactivation

• Hypotension

Serious side effects:

• Severe neuropathy

• Heart failure (rare)

• Pulmonary toxicity (rare)

Antiviral prophylaxis (e.g., acyclovir) is recommended.

Dosage

Dosage is based on body surface area (BSA).

Standard dose:

• 1.3 mg/m² per dose

Schedule:

• IV or SC on Days 1, 4, 8, and 11 of a 21-day cycle

2 mg vial is commonly used for single-dose preparation.

NOTE: This medicine should be taken only under a doctor’s supervision.

Established in:	2021
Bussiness Type:	Sole Proprietorship
Bussiness Type:	Merchant
MSME:	Yes
Countries exporting to:	United States, Philippines, Smaller Territories of the UK, United Kingdom, Bangladesh, Pakistan, Nepal, United Arab Emirates, Australia, Malaysia, Canada, Korea North, Korea South, Thailand, Mexico, Saudi Arabia, Bulgaria, Russia, Poland, Ethiopia, Zimbabwe, Taiwan, Albania, Azerbaijan, Brazil, Tanzania, Bhutan, France, Kuwait, Egypt, Vietnam, Belgium, Belarus, Congo, Czech Republic, Germany, Greece, Greenland, Indonesia, Iran, Israel, Italy, Japan, Jordan, Kenya, Latvia, Lebanon, Liberia, Lithuania, Macedonia, Afghanistan
Export Turnover (3 years):	US$10,000 to US$50,000
Countries would like to export to:	Austria, United States, United Kingdom, Turkey, Thailand, Switzerland, Sri Lanka, South Africa, Bangladesh, Albania, American Samoa, Anguilla, Malaysia, Canada, Korea North, Japan, Korea South, Uzbekistan, Azerbaijan, Bhutan, Belgium, Australia, Afghanistan, Mexico, France, Ethiopia, Germany, Netherlands Antilles, Tanzania, Turks And Caicos Islands, Italy, Bulgaria, Greece, Greenland, Indonesia, Iran, Iraq, Congo, Latvia, Lebanon, Liberia, Lithuania, Kenya, Central African Republic, United Arab Emirates, Philippines, Algeria, Andorra
No of employees:	1-10

BORTLIEVA (BORTEZOMIB INJECTION IP 2 MG /VIAL

Related Products

Bortenat 2mg

Artesunate Injection 60 mg

BORTENAT INJ 2.0MG

BORTENAT INJ 3.5MG

Medified RELIEF Tab.

HUCOG 5000 HP

Injection Plastic Moulds

ETAMSYLATE B.P. (TABLET & INJECTION GRADE)

Injection Molded Pallet

INJECTION PACKERS 150MM

INJECTION PACKERS 75MM

INJECTION PACKERS 100MM